| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule binding | MAP4 KIF26A APC2 ZNF207 TUBGCP2 DCTN1 MTCL1 MTUS2 SGIP1 GTSE1 TUBGCP6 CCDC88C MAP1S MARK4 MAST1 | 5.19e-06 | 308 | 240 | 15 | GO:0008017 |
| GeneOntologyMolecularFunction | SH3 domain binding | ABI3 WIPF3 SIRPG SYNJ1 RAD9A SGIP1 DTX1 DENND1A KHDRBS1 INPP5J | 9.22e-06 | 143 | 240 | 10 | GO:0017124 |
| GeneOntologyMolecularFunction | tubulin binding | MAP4 KIF26A APC2 WIPF3 ZNF207 TUBGCP2 DCTN1 MTCL1 MTUS2 SGIP1 GTSE1 WASHC1 TUBGCP6 CCDC88C MAP1S MARK4 MAST1 | 1.80e-05 | 428 | 240 | 17 | GO:0015631 |
| GeneOntologyMolecularFunction | gamma-tubulin binding | 8.74e-05 | 38 | 240 | 5 | GO:0043015 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ABI3 MAP4 KIF26A APC2 WIPF3 ZNF207 TUBGCP2 DCTN1 MTCL1 MYO18B USH2A UTRN MTUS2 MRTFA SHROOM3 SGIP1 GTSE1 WASHC1 MIB2 FMNL3 TUBGCP6 CCDC88C MAP1S MARK4 MAST1 KBTBD13 ATP1A1 MTSS2 | 1.46e-04 | 1099 | 240 | 28 | GO:0008092 |
| GeneOntologyMolecularFunction | potassium channel inhibitor activity | 2.63e-04 | 11 | 240 | 3 | GO:0019870 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | WNK1 MAST4 MAP3K10 WNK4 WNK2 CAMKK1 AATK CSNK2A1 MARK4 MAST1 PKN1 PRKD1 CSNK2A3 | 4.76e-04 | 363 | 240 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | methyl-CpG binding | 4.96e-04 | 31 | 240 | 4 | GO:0008327 | |
| Domain | NUT | 1.23e-07 | 5 | 236 | 4 | IPR024310 | |
| Domain | NUT_N | 1.23e-07 | 5 | 236 | 4 | IPR024309 | |
| Domain | NUT | 1.23e-07 | 5 | 236 | 4 | PF12881 | |
| Domain | OSR1_C | 3.87e-05 | 6 | 236 | 3 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 3.87e-05 | 6 | 236 | 3 | IPR024678 | |
| Domain | TMEM191C | 1.59e-04 | 2 | 236 | 2 | PF15194 | |
| Domain | TMEM191B/C | 1.59e-04 | 2 | 236 | 2 | IPR028186 | |
| Domain | WH2 | 2.16e-04 | 24 | 236 | 4 | PS51082 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 KIF26A NAGLU THAP8 C15orf39 SRCAP MBD6 ARHGEF11 WNK1 DCTN1 RYR1 KMT2C SYNJ1 SEC16A UNKL ZC3H7B SIPA1L2 PLXNA1 WNK2 IQCE RAD9A SEMA6C PNPLA2 SHROOM3 SZT2 PUF60 BICRA TMEM158 GTSE1 AOC2 ZBTB4 MIB2 MED13L FAAP100 DENND1A MFSD12 FAM83H MICALL1 CCDC88C HEYL AATK KLF10 MAP1S MEGF6 ADAMTS7 ARVCF MARK4 XXYLT1 PKN1 IRS2 SPEN | 2.45e-26 | 1105 | 252 | 51 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TNK1 ERBB2 MAP4 TEX2 SEC24A HJURP RTKN WNK1 MAST4 SYNJ1 SEC16A MAP3K10 MTCL1 SIPA1L2 UTRN WNK4 SHROOM3 IRS4 CAMKK1 GTSE1 CRTC1 DENND1A RGS12 E2F8 FAM83H MICALL1 CCDC88C KIAA1217 MARK4 IRS2 SH3RF3 MTSS2 | 4.42e-14 | 861 | 252 | 32 | 36931259 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | APC2 HJURP WNK1 PHC3 WNK4 WNK2 MRTFA IQCE SHROOM3 IRS4 BICRA DTX1 GTSE1 AATK MAP1S YLPM1 IGSF9B TMEM151A SPEN | 4.73e-10 | 430 | 252 | 19 | 35044719 |
| Pubmed | APC2 ARHGEF11 DCTN1 SIRPG KCNB1 SYNJ1 SEC16A MTCL1 WNK2 SHROOM3 SGIP1 PRR36 RANBP9 DVL2 KANK2 CCDC88C ARVCF CSNK2A1 ATF7IP KIAA1217 YLPM1 DCHS1 PKN1 PRKD1 FRMPD3 CTNND2 PCDH8 MTSS2 | 5.47e-10 | 963 | 252 | 28 | 28671696 | |
| Pubmed | MAP4 RPS2 PPP1R13L POLR1G WNK1 CTTNBP2NL RBM27 SEC16A MTCL1 MRTFA ZNF574 GTSE1 RRP8 TACC2 NUP35 LIG1 KLF10 PKN1 IRS2 SPEN | 1.01e-09 | 503 | 252 | 20 | 16964243 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | LINC00322 MAP4 PPP1R13L FCHO1 HMCN2 MTCL1 MYO18B CRTC1 MIB2 KANK2 PCF11 MAP1S KHDRBS1 ZFHX4 IRS2 CTNND2 SPEN | 1.53e-09 | 361 | 252 | 17 | 26167880 |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | ERBB2 C15orf39 ARHGEF11 RBM27 SEC16A ARHGAP29 SHROOM3 SCAF8 NUP35 PCF11 KHDRBS1 YLPM1 | 9.13e-09 | 180 | 252 | 12 | 35198878 |
| Pubmed | TUBGCP2 RTKN WNK1 CTTNBP2NL SEC16A MTCL1 SIPA1L2 UTRN SHROOM3 IRS4 CAMKK1 DENND1A CCDC88C MAP1S LRCH4 IRS2 SH3RF3 | 3.49e-08 | 446 | 252 | 17 | 24255178 | |
| Pubmed | ERBB2 KIF26A TEX2 CTTNBP2NL KMT2C NRXN3 MAST4 RBM27 ZC3H7B WNK2 IQCE SEMA6C SHROOM3 SZT2 CRTC1 MICALL1 FMNL3 TUBGCP6 | 7.58e-08 | 529 | 252 | 18 | 14621295 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SEC24A TUBGCP2 SPATA2 RTKN ARHGEF11 DCTN1 MAST4 SYNJ1 ARHGAP29 SIPA1L2 SHROOM3 GTSE1 DVL2 CRTC1 PATL1 KANK2 RGS12 FAM83H MICALL1 CCDC88C KIAA1217 ARHGAP12 ATP1A1 | 8.08e-08 | 853 | 252 | 23 | 28718761 |
| Pubmed | TMEM74B MAP4 ARHGEF11 RYR1 MYO18B WNK2 CCR10 BICRA DTX1 AIRE PCDHA12 PANX2 ELK3 SPEN | 1.53e-07 | 329 | 252 | 14 | 17474147 | |
| Pubmed | SEC24A C15orf39 SRCAP MBD6 SPATA2 KMT2C PHC3 RBM27 SEC16A FOXL1 IRS4 SCAF8 BICRA COP1 PATL1 RFX5 ARID3B PCF11 FOXP4 KLF10 KHDRBS1 ZFHX4 CSNK2A1 ATF7IP YLPM1 ELF4 ELK3 PAX9 ATP1A1 SPEN | 2.00e-07 | 1429 | 252 | 30 | 35140242 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | C15orf39 KMT2C PHC3 SYNJ1 SEC16A CIZ1 BICRA ADNP2 NLRP1 FAM90A1 ARID3B FOXP4 ZFHX4 ATF7IP NUTM2F | 2.61e-07 | 398 | 252 | 15 | 35016035 |
| Pubmed | Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer. | 3.76e-07 | 3 | 252 | 3 | 17852076 | |
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 19270645 | ||
| Pubmed | RPS2 TEX2 PPP1R13L CTTNBP2NL MAST4 SEC16A ARHGAP29 MTCL1 SIPA1L2 UTRN KANK2 | 4.19e-07 | 209 | 252 | 11 | 36779422 | |
| Pubmed | KIF26A ARHGEF11 WNK1 DCTN1 KMT2C KIAA1549L MAP3K10 WNK2 BICRA RANBP9 ADNP2 CRTC1 KHDRBS1 ATF7IP WASH2P MUC1 | 6.31e-07 | 486 | 252 | 16 | 20936779 | |
| Pubmed | ERBB2 TUBGCP2 SRCAP POLR1G HMCN2 SEC16A CIZ1 SIPA1L2 ZNF574 EP400P1 RNF31 BICRA TAF1C RANBP9 DVL2 ADNP2 KANK2 FAM83H TUBGCP6 FOXP4 SOWAHA ZFHX4 CSNK2A1 MARK4 IRS2 | 6.96e-07 | 1116 | 252 | 25 | 31753913 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | THAP8 UNKL ZNF541 FOXL1 ZBTB4 ADNP2 AIRE IRX6 RFX5 TFAP2B E2F8 HEYL FOXP4 PHOX2A KLF10 ZFHX4 HEY1 DMRTC2 DMRTB1 ELF4 ELK3 PAX9 | 9.40e-07 | 908 | 252 | 22 | 19274049 |
| Pubmed | TCTN3 IBA57 ERBB2 ZNF207 USP35 SIPA1L2 UTRN RAD9A RNF31 PUF60 GTSE1 WASHC1 AOC2 NDST2 RIOX1 TACC2 KANK2 FAAP100 FAM83H TUBGCP6 KHDRBS1 LOX CPXM1 ELF4 PRKD1 ZNF385C | 9.67e-07 | 1215 | 252 | 26 | 15146197 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MAP4 POLR1G CTTNBP2NL PHC3 SEC16A MRTFA SCAF8 GTSE1 PATL1 MICALL1 PCF11 TUBGCP6 LIG1 MAP1S CSNK2A1 YLPM1 PKN1 IRS2 ELK3 SPEN | 1.13e-06 | 774 | 252 | 20 | 15302935 |
| Pubmed | WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. | 1.50e-06 | 4 | 252 | 3 | 11571656 | |
| Pubmed | 1.50e-06 | 4 | 252 | 3 | 11498583 | ||
| Pubmed | GLTSCR1, ATM, PPP1R13L and CD3EAP Genetic Variants and Lung Cancer Risk in a Chinese Population. | 1.50e-06 | 4 | 252 | 3 | 30128886 | |
| Pubmed | 1.50e-06 | 4 | 252 | 3 | 34384519 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP4 RPS2 SRCAP WNK1 DCTN1 PHC3 SYNJ1 RBM27 SEC16A CIZ1 SIPA1L2 UTRN IRS4 PUF60 DVL2 TACC2 ATF7IP KIAA1217 YLPM1 IRS2 ATP1A1 | 5.32e-06 | 934 | 252 | 21 | 33916271 |
| Pubmed | WNK2 kinase is a novel regulator of essential neuronal cation-chloride cotransporters. | 7.40e-06 | 6 | 252 | 3 | 21733846 | |
| Pubmed | 7.40e-06 | 6 | 252 | 3 | 12504854 | ||
| Pubmed | 7.40e-06 | 6 | 252 | 3 | 18942147 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 8.67e-06 | 184 | 252 | 9 | 32908313 | |
| Pubmed | SIRPG TMEM145 PLCL2 SGIP1 SLITRK4 PANX2 RGS12 AATK ARVCF ATP1A1 CTNND2 ATP1A3 PCDH8 | 9.45e-06 | 405 | 252 | 13 | 38187761 | |
| Pubmed | MBD6 WNK1 FBLN2 KIAA1549L NUTM2B ZC3H7B WNK2 RNF31 PUF60 DVL2 TNS2 MEGF6 DMRTB1 ATP1A3 SPEN PCDH8 | 1.09e-05 | 608 | 252 | 16 | 16713569 | |
| Pubmed | 1.13e-05 | 104 | 252 | 7 | 10470851 | ||
| Pubmed | 1.29e-05 | 7 | 252 | 3 | 20525693 | ||
| Pubmed | C15orf39 DCTN1 PHC3 SYNJ1 SEC16A UTRN MRTFA IRS4 DVL2 CRTC1 ZFHX4 ATF7IP IRS2 | 1.32e-05 | 418 | 252 | 13 | 34709266 | |
| Pubmed | RTN4R PKDREJ TMEM191B MYO18B ZC3H7B MRTFA GTSE1 PANX2 MICALL1 TUBGCP6 INPP5J | 1.36e-05 | 300 | 252 | 11 | 10591208 | |
| Pubmed | MAP4 POLR1G CTTNBP2NL TRAPPC8 GRSF1 ARVCF CSNK2A1 ARHGAP12 PKN1 CTNND2 | 1.39e-05 | 246 | 252 | 10 | 15345747 | |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 1.44e-05 | 108 | 252 | 7 | 19531213 | |
| Pubmed | RPS2 WNK1 IRS4 CAMKK1 PUF60 CRTC1 RGS12 MICALL1 CSNK2A1 IRS2 | 1.90e-05 | 255 | 252 | 10 | 15324660 | |
| Pubmed | 2.05e-05 | 8 | 252 | 3 | 23387299 | ||
| Pubmed | 2.05e-05 | 8 | 252 | 3 | 23838290 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | MAP4 NUTM2A ZNF207 PHC3 NUTM2B RBM27 SEC16A CIZ1 IRS4 PUF60 BICRA GTSE1 RRP8 RFX5 ARID3B PCF11 KHDRBS1 ATF7IP YLPM1 SPEN | 2.44e-05 | 954 | 252 | 20 | 36373674 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | RPS2 SEC24A C15orf39 PPP1R13L SPATA2 RTKN WNK1 SEC16A ARHGAP29 MRTFA GTSE1 DVL2 CRTC1 PATL1 KANK2 FRAT2 DENND1A CSNK2A1 KIAA1217 ARHGAP12 IRS2 | 2.56e-05 | 1038 | 252 | 21 | 26673895 |
| Pubmed | PPP1R13L DCTN1 MAST4 PLCL2 UTRN PNPLA2 RANBP9 TSKU FMNL3 HEYL KLF10 KHDRBS1 HEY1 ATF7IP YLPM1 | 3.12e-05 | 591 | 252 | 15 | 15231748 | |
| Pubmed | 3.72e-05 | 125 | 252 | 7 | 29467281 | ||
| Pubmed | MAP4 ZNF207 POLR1G ARHGEF11 CTTNBP2NL KMT2C PHC3 RBM27 CIZ1 ZC3H7B UTRN ZNF574 SHROOM3 SCAF8 TAF1C CRTC1 RRP8 KANK2 DENND1A GRSF1 NUP35 PCF11 CSNK2A1 LRCH4 CTNND2 SPEN | 3.80e-05 | 1497 | 252 | 26 | 31527615 | |
| Pubmed | 4.81e-05 | 28 | 252 | 4 | 38324473 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 32245295 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 20550696 | ||
| Pubmed | The clinical significance of small copy number variants in neurodevelopmental disorders. | 5.23e-05 | 2 | 252 | 2 | 25106414 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 16194893 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 21704025 | ||
| Pubmed | Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2. | 5.23e-05 | 2 | 252 | 2 | 14646071 | |
| Pubmed | Erb-B2 homodimerization inhibits MUC1 transcription in cultured human mammary epithelial cells. | 5.23e-05 | 2 | 252 | 2 | 12798775 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 21151495 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 10523317 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 30011875 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 22294159 | ||
| Pubmed | All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides. | 5.23e-05 | 2 | 252 | 2 | 11546672 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 22197173 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 25531720 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 27974697 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 24391932 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 20598042 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 27003157 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 24039759 | ||
| Pubmed | Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. | 5.23e-05 | 2 | 252 | 2 | 12860116 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 23624123 | ||
| Pubmed | Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. | 5.23e-05 | 2 | 252 | 2 | 16899520 | |
| Pubmed | Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons. | 5.23e-05 | 2 | 252 | 2 | 23761886 | |
| Pubmed | Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer. | 5.23e-05 | 2 | 252 | 2 | 19060592 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 23687433 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 25113964 | ||
| Pubmed | The family of human Na+,K+-ATPase genes. A partial nucleotide sequence related to the alpha-subunit. | 5.23e-05 | 2 | 252 | 2 | 3030810 | |
| Pubmed | Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC. | 5.23e-05 | 2 | 252 | 2 | 29846116 | |
| Pubmed | Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer. | 5.23e-05 | 2 | 252 | 2 | 24879526 | |
| Pubmed | WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia. | 5.23e-05 | 2 | 252 | 2 | 35849656 | |
| Pubmed | WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription. | 5.23e-05 | 2 | 252 | 2 | 29196535 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 21498719 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 22335888 | ||
| Pubmed | Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival. | 5.23e-05 | 2 | 252 | 2 | 24551091 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 23635475 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 24962901 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 12671053 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 17616686 | ||
| Pubmed | Assignment of casein kinase 2 alpha sequences to two different human chromosomes. | 5.23e-05 | 2 | 252 | 2 | 1577469 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 23925696 | ||
| Pubmed | Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis. | 5.23e-05 | 2 | 252 | 2 | 26246541 | |
| Pubmed | Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge. | 5.23e-05 | 2 | 252 | 2 | 27327081 | |
| Pubmed | Ubiquitin Ligase COP1 Controls Hepatic Fat Metabolism by Targeting ATGL for Degradation. | 5.23e-05 | 2 | 252 | 2 | 27658392 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 25682076 | ||
| Pubmed | Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy. | 5.23e-05 | 2 | 252 | 2 | 33951110 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 30553442 | ||
| Pubmed | Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function. | 5.23e-05 | 2 | 252 | 2 | 24968021 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 26838233 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 25444743 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 15051890 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 16820787 | ||
| Pubmed | Molecular cloning of the human casein kinase II alpha subunit. | 5.23e-05 | 2 | 252 | 2 | 2752008 | |
| Pubmed | Structure and sequence of an intronless gene for human casein kinase II-alpha subunit. | 5.23e-05 | 2 | 252 | 2 | 8420794 | |
| Interaction | TOP3B interactions | ERBB2 KIF26A SEC24A NAGLU THAP8 C15orf39 SRCAP MBD6 ARHGEF11 WNK1 DCTN1 RYR1 KMT2C SYNJ1 SEC16A UNKL ZC3H7B SIPA1L2 PLXNA1 WNK2 IQCE RAD9A FOXL1 SEMA6C PNPLA2 SHROOM3 SZT2 PUF60 BICRA TMEM158 GTSE1 AOC2 ZBTB4 DVL2 MIB2 PATL1 MED13L KANK2 FAAP100 DENND1A GRSF1 MFSD12 FAM83H MICALL1 CCDC88C HEYL AATK KLF10 MAP1S MEGF6 ADAMTS7 ARVCF MARK4 XXYLT1 PKN1 IRS2 SPEN | 5.02e-16 | 1470 | 237 | 57 | int:TOP3B |
| Interaction | YWHAH interactions | TNK1 TEX2 SEC24A HJURP RTKN WNK1 DCTN1 MAST4 SYNJ1 SEC16A MAP3K10 MTCL1 SIPA1L2 UTRN WNK2 SHROOM3 IRS4 CAMKK1 GTSE1 TNS2 CRTC1 DENND1A RGS12 E2F8 FAM83H MICALL1 CCDC88C KIAA1217 MARK4 MAST1 PRKD1 IRS2 SH3RF3 MTSS2 | 2.53e-07 | 1102 | 237 | 34 | int:YWHAH |
| Interaction | YWHAB interactions | TNK1 SEC24A HJURP RTKN WNK1 DCTN1 MAST4 USP32 MAP3K10 MTCL1 SIPA1L2 SHROOM3 IRS4 CAMKK1 RANBP9 DVL2 COP1 TNS2 CRTC1 TRAPPC8 DENND1A RGS12 E2F8 FAM83H MICALL1 CCDC88C CSNK2A1 MARK4 MAST1 IRS2 SH3RF3 MTSS2 | 3.61e-07 | 1014 | 237 | 32 | int:YWHAB |
| Interaction | YWHAE interactions | TNK1 SEC24A HJURP MBD6 SPATA2 RTKN WNK1 DCTN1 MAST4 MAP3K10 SIPA1L2 WNK2 SHROOM3 IRS4 CAMKK1 RNF31 GTSE1 DVL2 TNS2 CRTC1 TACC2 KANK2 DENND1A RGS12 E2F8 FAM83H ARID3B MICALL1 CCDC88C MARK4 MAST1 PRKD1 IRS2 ATP1A1 SH3RF3 | 1.76e-06 | 1256 | 237 | 35 | int:YWHAE |
| Interaction | YWHAG interactions | TNK1 RPS2 SEC24A HJURP RTKN WNK1 MAST4 SYNJ1 SEC16A ARHGAP29 MAP3K10 MTCL1 SIPA1L2 UTRN SHROOM3 IRS4 CAMKK1 RNF31 PUF60 GTSE1 DVL2 TNS2 CRTC1 DENND1A RGS12 E2F8 FAM83H MICALL1 CCDC88C MARK4 PRKD1 IRS2 SH3RF3 MTSS2 | 4.12e-06 | 1248 | 237 | 34 | int:YWHAG |
| Interaction | SRPK2 interactions | LINC00322 MAP4 PPP1R13L FCHO1 HMCN2 RBM27 UNKL MTCL1 MYO18B PUF60 TAF1C CRTC1 RRP8 MIB2 FAM90A1 KANK2 GRSF1 PCF11 MAP1S KHDRBS1 ZFHX4 ARHGAP12 IRS2 SPEN | 4.37e-06 | 717 | 237 | 24 | int:SRPK2 |
| Interaction | YWHAZ interactions | TNK1 ERBB2 TEX2 SEC24A HJURP SPATA2 RTKN WNK1 DCTN1 MAST4 RBM27 ARHGAP29 MAP3K10 SIPA1L2 WNK2 SHROOM3 IRS4 PUF60 COP1 CRTC1 TACC2 KANK2 DENND1A RGS12 E2F8 FAM83H ARID3B MICALL1 CCDC88C MARK4 MAST1 PRKD1 IRS2 ATP1A1 MTSS2 | 5.22e-06 | 1319 | 237 | 35 | int:YWHAZ |
| Interaction | DTX2 interactions | ERBB2 C15orf39 ARHGEF11 RBM27 SEC16A ARHGAP29 SHROOM3 SCAF8 DTX1 KANK2 NUP35 PCF11 KHDRBS1 YLPM1 | 3.90e-05 | 330 | 237 | 14 | int:DTX2 |
| Interaction | VASP interactions | ABI3 SEC24A CTTNBP2NL SYNJ1 SEC16A SIPA1L2 MRTFA SHROOM3 DVL2 CRTC1 KANK2 DMRTB1 IRS2 | 4.84e-05 | 294 | 237 | 13 | int:VASP |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | PLVAP MBD3L2 APC2 TGFBR3L GDF1 FCHO1 CILP2 ZNF358 MED26 PRSS57 PRR36 MUC16 CRTC1 MBD3L3 KANK2 MFSD12 MBD3L2B MAP1S MAST1 PKN1 | 2.29e-08 | 797 | 252 | 20 | chr19p13 |
| Cytoband | 19p13.2 | PLVAP MBD3L2 TGFBR3L ZNF358 PRR36 MUC16 MBD3L3 KANK2 MBD3L2B MAST1 | 6.50e-07 | 229 | 252 | 10 | 19p13.2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | LRFN3 THAP8 PPP1R13L POLR1G RYR1 GFY TMEM145 SIGLEC10 MAP3K10 ZNF541 ZNF574 BICRA LAIR1 LIG1 KASH5 MARK4 DMRTC2 ACP4 ATP1A3 | 3.80e-05 | 1192 | 252 | 19 | chr19q13 |
| Cytoband | 19p13.11 | 5.31e-05 | 73 | 252 | 5 | 19p13.11 | |
| GeneFamily | PDZ domain containing | 2.97e-05 | 152 | 144 | 8 | 1220 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.23e-04 | 181 | 144 | 7 | 694 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 1.29e-03 | 7 | 144 | 2 | 1208 | |
| GeneFamily | Fibulins | 1.71e-03 | 8 | 144 | 2 | 556 | |
| GeneFamily | Fibronectin type III domain containing | 1.79e-03 | 160 | 144 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.84e-03 | 161 | 144 | 6 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.96e-03 | 163 | 144 | 6 | 590 | |
| GeneFamily | Zinc fingers CCCH-type | 2.69e-03 | 35 | 144 | 3 | 73 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | SRCAP RTKN ARHGEF11 ZNF358 ZC3H7B SEMA6C SZT2 BICRA TAF1C SEC31B KHDC4 MICALL1 NUTM2E HEYL LRCH4 MTSS2 | 1.84e-07 | 338 | 250 | 16 | M17094 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | CDKN1C TCERG1L FCHO1 FBLN2 KCNB1 ARHGAP29 MTUS2 WNK4 DTX1 SLITRK4 CGAS IRX6 AATK ARVCF LOX KIAA1217 CPXM1 ATP1A3 | 1.40e-06 | 493 | 250 | 18 | M1951 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | CDKN1C TCERG1L FCHO1 FBLN2 KCNB1 ARHGAP29 MTUS2 WNK4 DTX1 SLITRK4 CGAS IRX6 AATK ARVCF LOX KIAA1217 CPXM1 ATP1A3 | 1.91e-06 | 504 | 250 | 18 | MM830 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | CDKN1C ERBB2 TCERG1L HJURP PKDREJ FBLN2 ARHGAP29 UTRN WNK4 PIF1 SHROOM3 IRS4 CGAS IGDCC3 SEC31B E2F8 TSKU CCDC88C HEYL FOXP4 SOWAHA ADAMTS7 LOX KIAA1217 MAST1 CPXM1 PCDH8 | 4.78e-06 | 1074 | 250 | 27 | M1941 |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | DCTN1 PARP6 C3orf80 ZBTB4 CGAS RFX5 DENND1A ADAMTS7 ELK3 SPEN | 2.30e-05 | 199 | 250 | 10 | M7451 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TMEM74B TCERG1L APC2 NUTM2A NRXN3 MAST4 KIAA1549L SYNJ1 MTUS2 PLXNA1 SLITRK4 MED13L VWCE SEC31B SEZ6L2 ZNF385D AATK ZFHX4 MEGF6 MAST1 IGSF9B FRMPD3 TMEM151A CTNND2 ATP1A3 PCDH8 | 2.31e-05 | 1106 | 250 | 26 | M39071 |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 2.40e-05 | 200 | 250 | 10 | M302 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RYR1 PLCL2 ZNF541 SLITRK4 PCDHA12 CCDC88C HECTD2 MAST1 PRKD1 SH3RF3 | 3.71e-08 | 165 | 252 | 10 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RYR1 PLCL2 ZNF541 SLITRK4 PCDHA12 CCDC88C HECTD2 MAST1 PRKD1 SH3RF3 | 3.71e-08 | 165 | 252 | 10 | b4f7d33af7d053ec07b01bd67d861600a9c4822e |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PLVAP NRXN3 TMEM145 MTUS2 PANX2 TFAP2B PHOX2A MAST1 FRMPD3 ATP1A3 | 5.20e-08 | 171 | 252 | 10 | 99176a932569fa1c7e1c01009684f5a65244b96e |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | TMEM145 SEMA6C FAM131C TFAP2B FAM83H MARK4 MAST1 ZNF385C INPP5J | 4.87e-07 | 167 | 252 | 9 | 9efb9511a211d0824bb97f82c1a5860c43d2138f |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | TMEM145 SEMA6C FAM131C TFAP2B FAM83H MARK4 MAST1 ZNF385C INPP5J | 4.87e-07 | 167 | 252 | 9 | 904c613aac3f9919a432b110bb1dcc832b5aec0a |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TMEM74B KIF26A CTTNBP2NL FBLN2 HMCN2 KIAA1549L UTRN FOXL1 INPP5J | 5.39e-07 | 169 | 252 | 9 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.32e-07 | 178 | 252 | 9 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.32e-07 | 178 | 252 | 9 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-5|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 9.84e-07 | 134 | 252 | 8 | d4b175257c47916ed90cdb5c555c2b26530ce8d5 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.20e-06 | 186 | 252 | 9 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-06 | 188 | 252 | 9 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-06 | 188 | 252 | 9 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-06 | 188 | 252 | 9 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-06 | 193 | 252 | 9 | 3a9fe4e709c09ec787c71bdd6b58a71c419896de | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma|TCGA-Adrenal / Sample_Type by Project: Shred V9 | FAM162B MTCL1 NLRP1 TFAP2B PHOX2A MAST1 TMEM151A CTNND2 ATP1A3 | 1.70e-06 | 194 | 252 | 9 | b6488bc3a8905e926ad298332963e1bbaf010046 |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma|TCGA-Adrenal / Sample_Type by Project: Shred V9 | FAM162B MTCL1 NLRP1 TFAP2B PHOX2A MAST1 TMEM151A CTNND2 ATP1A3 | 1.70e-06 | 194 | 252 | 9 | 1e1f4139ad584f493d75a9b7f1568eca4653c5a2 |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 195 | 252 | 9 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 196 | 252 | 9 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.18e-06 | 200 | 252 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.93e-06 | 155 | 252 | 8 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.23e-06 | 157 | 252 | 8 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.89e-06 | 161 | 252 | 8 | f4f5d6eaa32169de699c8ff8e8ae35179c8e25c0 | |
| ToppCell | Multiple_Sclerosis-Other-HSPC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.46e-06 | 164 | 252 | 8 | 6af5529507d695b347adee4be5ead70f56c9cf55 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.10e-06 | 167 | 252 | 8 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.33e-06 | 168 | 252 | 8 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.57e-06 | 169 | 252 | 8 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | mild_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 5.81e-06 | 170 | 252 | 8 | 85c476e0bc496445e868a88849960598d97bdea2 | |
| ToppCell | Pericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.07e-06 | 171 | 252 | 8 | bbc8d9fc83d37c9250345b1e76776610799de9ae | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-06 | 173 | 252 | 8 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.89e-06 | 174 | 252 | 8 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.89e-06 | 174 | 252 | 8 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-06 | 175 | 252 | 8 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-06 | 175 | 252 | 8 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-06 | 175 | 252 | 8 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.81e-06 | 177 | 252 | 8 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-06 | 179 | 252 | 8 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-06 | 180 | 252 | 8 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 8.83e-06 | 180 | 252 | 8 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-06 | 180 | 252 | 8 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-06 | 181 | 252 | 8 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.97e-06 | 183 | 252 | 8 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 184 | 252 | 8 | f17d713af4a97dff4eeeab24c405677ef2ffcf84 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 185 | 252 | 8 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.08e-05 | 185 | 252 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-05 | 185 | 252 | 8 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-05 | 186 | 252 | 8 | 7a8da2ad140bea3207bd868212cc5e201d586772 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-05 | 186 | 252 | 8 | dc394034929c6b10ae0e1c1a028cc3d4ce873298 | |
| ToppCell | Mild/Remission-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.14e-05 | 134 | 252 | 7 | 5bd1e3fa6278facd9e949e9e5e244e700190126b | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-05 | 187 | 252 | 8 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 187 | 252 | 8 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-05 | 187 | 252 | 8 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 189 | 252 | 8 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 189 | 252 | 8 | a34f008dfcee4012977bbc5b60de6f0329ca2f65 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 190 | 252 | 8 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-05 | 190 | 252 | 8 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 190 | 252 | 8 | ec6b8e2852e1cce0217ff61243defe98b2351640 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 191 | 252 | 8 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | PND01-Endothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-05 | 191 | 252 | 8 | 96b9b0aaf0cb2d6f929ff563dbaedc83ffb4795e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.36e-05 | 191 | 252 | 8 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 191 | 252 | 8 | 04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-05 | 191 | 252 | 8 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.36e-05 | 191 | 252 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 191 | 252 | 8 | db8dd6bbba803585bdd6a55d5c403d383f2e9acf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 192 | 252 | 8 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 192 | 252 | 8 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 192 | 252 | 8 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-05 | 193 | 252 | 8 | 6a623acd1adad9a78eddc32ffedb16352ad3fdfa | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte-|COVID-19_Severe / Disease condition and Cell class | 1.52e-05 | 194 | 252 | 8 | d70b9039fd2fef3e4be086513b94fb7e9bc1f670 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 194 | 252 | 8 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / Disease condition and Cell class | 1.52e-05 | 194 | 252 | 8 | 5151546812678ae85cb22224084d27b29e3c4724 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 195 | 252 | 8 | 52b2bbf12e5f86c493f6634697aeb23a68cc916d | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 195 | 252 | 8 | e5f14f6015ea5e6fa065f906ad22157e3de15c68 | |
| ToppCell | facs-Thymus-Epithelium-24m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 195 | 252 | 8 | cc89261bb091ef978bd73cffc68ccdd00a8786d1 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.58e-05 | 195 | 252 | 8 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 196 | 252 | 8 | 9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc | |
| ToppCell | facs-Lung-ENDOMUCIN-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 196 | 252 | 8 | f6df26ab9eebae893768a4f70a064ce9f60da93c | |
| ToppCell | facs-Lung-ENDOMUCIN|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 196 | 252 | 8 | 69f03546c42c942ab8ac8746167c8d44d574b4c6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.64e-05 | 196 | 252 | 8 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 196 | 252 | 8 | 04dfef1bd4ebb0e9469ae80024dc177e469a2560 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-05 | 197 | 252 | 8 | f4834378d5d31560b4efe5dee0d5b5d11caeb10f | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-05 | 197 | 252 | 8 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 197 | 252 | 8 | b1c6a15bf6c0645952a7247182dc71baf4736869 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-05 | 198 | 252 | 8 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-05 | 198 | 252 | 8 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-05 | 198 | 252 | 8 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-05 | 198 | 252 | 8 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-05 | 198 | 252 | 8 | 88b4662be9cc933a402c52673fa5e00fa979c0db | |
| ToppCell | Biopsy_Control_(H.)-Endothelial-Lymphatic_Endothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.89e-05 | 200 | 252 | 8 | 8cf218887ab030b7625610cb65b595170a17ebec | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-05 | 155 | 252 | 7 | 5d157478669b609e1f0f0a75afd0112571fc2c46 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-3|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.05e-05 | 156 | 252 | 7 | b464871ad7c8ce0d58013a27996639eac1e526d8 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.44e-05 | 159 | 252 | 7 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | LA-04._Ventricular_Cardiomyocyte_I|LA / Chamber and Cluster_Paper | 3.83e-05 | 110 | 252 | 6 | 34dcd1e1e16e8b6088ff9a7a40532e8bd000c121 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-05 | 163 | 252 | 7 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | IIF-Other-HSPC|IIF / Disease, Lineage and Cell Type | 4.03e-05 | 163 | 252 | 7 | 1e0d38fbed38ac48478868a1480172a1a3f7c1b7 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.03e-05 | 163 | 252 | 7 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.19e-05 | 164 | 252 | 7 | d2218d50e0e2d19f919dcb460b3840687c082810 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-05 | 165 | 252 | 7 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-05 | 166 | 252 | 7 | 4d63c758d46e73311b864148c646bf081498dee7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-05 | 166 | 252 | 7 | 4160ccf9291072a6e2782f9ad141bc9a9747f3ad | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.70e-05 | 167 | 252 | 7 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| Drug | Fluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A | MAP4 C15orf39 BCL2 TUBGCP2 PHC3 MRTFA PRR36 SZT2 TAF1C RGS12 MARK4 CTNND2 | 1.67e-06 | 196 | 247 | 12 | 7348_DN |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A | NAGLU TUBGCP2 SRCAP ARHGEF11 ZC3H7B MRTFA IQCE TAF1C RGS12 ARVCF IRS2 MUC1 | 1.76e-06 | 197 | 247 | 12 | 3431_UP |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | LRFN3 NAGLU ZNF358 CIZ1 ZC3H7B MRTFA PRR36 NDST2 LAIR1 MARK4 IRS2 MUC1 | 1.85e-06 | 198 | 247 | 12 | 3843_DN |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A | C15orf39 PPP1R13L POLR1G MTCL1 DUSP8 E2F8 MICALL1 PCF11 DNAAF2 KLF10 ELF4 | 8.13e-06 | 191 | 247 | 11 | 5210_DN |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | RPS2 SRCAP MAST4 ZC3H7B UTRN MRTFA CRTC1 PHOX2A MEGF6 ARVCF MARK4 | 9.43e-06 | 194 | 247 | 11 | 4422_DN |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | MAP4 SRCAP PHC3 PLXNA1 IQCE PRR36 KANK2 FAAP100 LIG1 CTNND2 MUC1 | 1.04e-05 | 196 | 247 | 11 | 1696_DN |
| Drug | AG-028671 [847803-03-6]; Down 200; 10uM; MCF7; HT_HG-U133A | SEC24A SRCAP POLR1G UTRN PLXNA1 PNPLA2 PRR36 BICRA CCDC88C ARVCF MARK4 | 1.14e-05 | 198 | 247 | 11 | 6587_DN |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; HL60; HT_HG-U133A | ARHGEF11 WNK1 NCR2 MRTFA PNMA3 WSCD1 AIRE TNS2 HEYL PHOX2A MARK4 | 1.14e-05 | 198 | 247 | 11 | 2369_UP |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | CDKN1C ARHGEF11 PHC3 NCR2 ZC3H7B UTRN WSCD1 RGS12 AATK CTF1 IGSF9B | 1.26e-05 | 200 | 247 | 11 | 4837_UP |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | C15orf39 BCL2 ARHGEF11 ZC3H7B PLXNA1 DUSP8 KANK2 E2F8 PCF11 ELF4 | 4.75e-05 | 191 | 247 | 10 | 941_DN |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | C15orf39 MAST4 IQCE DUSP8 TNS2 PCF11 DNAAF2 CCDC88C KLF10 MUC1 | 4.96e-05 | 192 | 247 | 10 | 5222_DN |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | LRFN3 SRCAP MAST4 NCR2 PNPLA2 PRR36 CRTC1 RGS12 MICALL1 CSNK2A1 | 5.18e-05 | 193 | 247 | 10 | 3973_DN |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A | 5.65e-05 | 195 | 247 | 10 | 4433_DN | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; HL60; HG-U133A | 5.90e-05 | 196 | 247 | 10 | 2033_UP | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 5.90e-05 | 196 | 247 | 10 | 4415_DN | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 5.90e-05 | 196 | 247 | 10 | 4779_DN | |
| Drug | Josamycin [16846-24-5]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 5.90e-05 | 196 | 247 | 10 | 5692_UP | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 5.90e-05 | 196 | 247 | 10 | 4347_DN | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.90e-05 | 196 | 247 | 10 | 1082_UP | |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | 5.90e-05 | 196 | 247 | 10 | 3936_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | C15orf39 PHC3 ZNF358 CIZ1 NCR2 ZC3H7B PNPLA2 PRR36 LAIR1 CCDC88C | 6.16e-05 | 197 | 247 | 10 | 3862_DN |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | 6.16e-05 | 197 | 247 | 10 | 6964_UP | |
| Drug | Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A | ERBB2 MAP4 SRCAP ZC3H7B PNPLA2 RGS12 CCDC88C MAP1S ARVCF MUC1 | 6.16e-05 | 197 | 247 | 10 | 3235_DN |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | MAP4 ARHGEF11 CIZ1 MTCL1 ZNF574 RNF31 CRTC1 RGS12 MARK4 MUC1 | 6.16e-05 | 197 | 247 | 10 | 3484_UP |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | ERBB2 SRCAP PHC3 PNRC1 PNPLA2 BICRA GTSE1 MICALL1 PKN1 CTNND2 | 6.16e-05 | 197 | 247 | 10 | 2763_DN |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A | ERBB2 MAP4 PHC3 MAST4 PLXNA1 PNPLA2 RNF31 TNS2 SEZ6L2 CTNND2 | 6.16e-05 | 197 | 247 | 10 | 1698_DN |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 6.42e-05 | 198 | 247 | 10 | 6353_DN | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 6.42e-05 | 198 | 247 | 10 | 6925_UP | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; HL60; HT_HG-U133A | 6.42e-05 | 198 | 247 | 10 | 2358_UP | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 6.42e-05 | 198 | 247 | 10 | 3175_DN | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; HL60; HT_HG-U133A | ARHGEF11 WNK1 CIZ1 PNPLA2 BICRA NLRP1 MED13L MARK4 ELF4 PKN1 | 6.42e-05 | 198 | 247 | 10 | 1316_DN |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; MCF7; HT_HG-U133A | MAP4 NCR2 ZC3H7B WSCD1 PNPLA2 PRR36 FAAP100 RGS12 ARVCF MUC1 | 6.42e-05 | 198 | 247 | 10 | 2797_UP |
| Drug | Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; HL60; HT_HG-U133A | 6.42e-05 | 198 | 247 | 10 | 2575_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; HL60; HT_HG-U133A | 6.42e-05 | 198 | 247 | 10 | 1866_UP | |
| Drug | Reserpinic acid hydrochloride; Up 200; 9.2uM; PC3; HT_HG-U133A | 6.42e-05 | 198 | 247 | 10 | 6603_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 6.70e-05 | 199 | 247 | 10 | 3344_DN | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 6.70e-05 | 199 | 247 | 10 | 6132_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; HL60; HG-U133A | MAP4 TUBGCP2 ARHGEF11 FCHO1 UTRN PNMA3 LAIR1 SEC31B ARVCF YLPM1 | 6.70e-05 | 199 | 247 | 10 | 1768_UP |
| Drug | Theobromine [83-67-0]; Up 200; 22.2uM; PC3; HT_HG-U133A | 6.99e-05 | 200 | 247 | 10 | 6613_UP | |
| Drug | Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 6.99e-05 | 200 | 247 | 10 | 7463_UP | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.04e-04 | 170 | 247 | 9 | 965_UP | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 1.02e-05 | 6 | 238 | 3 | DOID:4479 (implicated_via_orthology) | |
| Disease | Metastatic melanoma | 7.50e-05 | 54 | 238 | 5 | C0278883 | |
| Disease | Pseudohypoaldosteronism type 2A | 3.85e-04 | 4 | 238 | 2 | cv:C1840389 | |
| Disease | Pseudohypoaldosteronism, type 2 | 3.85e-04 | 4 | 238 | 2 | cv:C1449844 | |
| Disease | complex cortical dysplasia with other brain malformations (is_implicated_in) | 3.85e-04 | 4 | 238 | 2 | DOID:0090131 (is_implicated_in) | |
| Disease | cognitive function measurement | TCERG1L MAP4 BCL2 NRXN3 MAST4 KCNB1 PLCL2 MYO18B USH2A WNK2 MRTFA SZT2 TFAP2B TSKU ZNF385D PHOX2A ATF7IP KIAA1217 XXYLT1 MAST1 PRKD1 IGSF9B CTNND2 SH3RF3 | 6.15e-04 | 1434 | 238 | 24 | EFO_0008354 |
| Disease | X-24020 measurement | 6.38e-04 | 5 | 238 | 2 | EFO_0022128 | |
| Disease | Endometrial Stromal Sarcoma | 6.38e-04 | 5 | 238 | 2 | C0206630 | |
| Disease | influenza A (H1N1) | 7.06e-04 | 87 | 238 | 5 | EFO_1001488 | |
| Disease | Clear cell sarcoma of kidney | 9.51e-04 | 6 | 238 | 2 | C0334488 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 1.32e-03 | 7 | 238 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Childhood Oligodendroglioma | 1.32e-03 | 7 | 238 | 2 | C0280475 | |
| Disease | Adult Oligodendroglioma | 1.32e-03 | 7 | 238 | 2 | C0279070 | |
| Disease | Oligodendroblastoma | 1.32e-03 | 7 | 238 | 2 | C0344461 | |
| Disease | Mixed Oligodendroglioma-Astrocytoma | 1.32e-03 | 7 | 238 | 2 | C0280793 | |
| Disease | Mixed Oligodendroglioma-Ependymoma | 1.32e-03 | 7 | 238 | 2 | C0751395 | |
| Disease | Well Differentiated Oligodendroglioma | 1.32e-03 | 7 | 238 | 2 | C0751396 | |
| Disease | oligodendroglioma | 1.76e-03 | 8 | 238 | 2 | C0028945 | |
| Disease | phenol sulfate measurement | 1.76e-03 | 8 | 238 | 2 | EFO_0021011 | |
| Disease | pseudohypoaldosteronism (is_implicated_in) | 1.76e-03 | 8 | 238 | 2 | DOID:4479 (is_implicated_in) | |
| Disease | Anaplastic Oligodendroglioma | 1.76e-03 | 8 | 238 | 2 | C0334590 | |
| Disease | Parkinsonism, Juvenile | 1.79e-03 | 30 | 238 | 3 | C0752105 | |
| Disease | amnestic disorder (implicated_via_orthology) | 2.25e-03 | 9 | 238 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | epilepsy (is_implicated_in) | 2.25e-03 | 9 | 238 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | neuroticism measurement, cognitive function measurement | FCHO1 PLCL2 COP1 PCDHA12 DENND1A AATK HECTD2 KIAA1217 YLPM1 IGSF9B TMEM151A CTNND2 | 2.31e-03 | 566 | 238 | 12 | EFO_0007660, EFO_0008354 |
| Disease | comparative body size at age 10, self-reported | WNK1 NRXN3 MAST4 ZC3H7B SIPA1L2 RAD9A MED13L TFAP2B AATK PRKD1 | 2.31e-03 | 420 | 238 | 10 | EFO_0009819 |
| Disease | Carcinoma, Granular Cell | 2.54e-03 | 116 | 238 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.54e-03 | 116 | 238 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.54e-03 | 116 | 238 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.54e-03 | 116 | 238 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.54e-03 | 116 | 238 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 2.54e-03 | 116 | 238 | 5 | C0001418 | |
| Disease | pack-years measurement, systolic blood pressure | 2.58e-03 | 34 | 238 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | Pseudohypoaldosteronism, Type I | 2.79e-03 | 10 | 238 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 2.79e-03 | 10 | 238 | 2 | C0033805 | |
| Disease | dry eye syndrome (is_marker_for) | 2.79e-03 | 10 | 238 | 2 | DOID:10140 (is_marker_for) | |
| Disease | Hyperpotassemia and Hypertension, Familial | 2.79e-03 | 10 | 238 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 2.79e-03 | 10 | 238 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 2.79e-03 | 10 | 238 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 2.79e-03 | 10 | 238 | 2 | C1449842 | |
| Disease | hypertrophic cardiomyopathy (biomarker_via_orthology) | 2.79e-03 | 10 | 238 | 2 | DOID:11984 (biomarker_via_orthology) | |
| Disease | allergic rhinitis (biomarker_via_orthology) | 2.79e-03 | 10 | 238 | 2 | DOID:4481 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | ERBB2 APC2 BCL2 WNK1 PKDREJ ARHGAP29 SPOCD1 ZNF541 TACC2 PANX2 TRAPPC8 MICALL1 HEYL FOXP4 HEY1 ELK3 SPEN PCDH8 | 2.90e-03 | 1074 | 238 | 18 | C0006142 |
| Disease | intellectual disability (implicated_via_orthology) | 3.21e-03 | 75 | 238 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | gallbladder neoplasm | 3.40e-03 | 11 | 238 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 3.40e-03 | 11 | 238 | 2 | C0153452 | |
| Disease | Bipolar I disorder | 3.40e-03 | 11 | 238 | 2 | C0853193 | |
| Disease | nervous system disease (implicated_via_orthology) | 4.05e-03 | 12 | 238 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Mesothelioma | 4.41e-03 | 41 | 238 | 3 | C0025500 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 5.04e-03 | 43 | 238 | 3 | DOID:9261 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.17e-03 | 195 | 238 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | KIF26A NRXN3 POM121L12 PLCL2 SIPA1L2 USH2A UTRN SGIP1 TACC2 DENND1A TFAP2B PHOX2A AATK IGSF9B | 5.81e-03 | 801 | 238 | 14 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Situs ambiguus | 6.35e-03 | 15 | 238 | 2 | C0266642 | |
| Disease | Sclerocystic Ovaries | 6.36e-03 | 144 | 238 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 6.36e-03 | 144 | 238 | 5 | C0032460 | |
| Disease | cutaneous Leishmaniasis | 7.22e-03 | 16 | 238 | 2 | EFO_0005046 | |
| Disease | nervousness | 7.22e-03 | 16 | 238 | 2 | NCIT_C74532 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 7.33e-03 | 346 | 238 | 8 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | cognitive inhibition measurement | 7.68e-03 | 50 | 238 | 3 | EFO_0007969 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPGPLALRPAPTAAT | 376 | Q66K41 | |
| PTAATTLFPAPILGP | 386 | Q66K41 | |
| LRPAPGPIRTAHTPV | 376 | Q9H6B1 | |
| SGSTPLGPLARVPPT | 61 | Q8IVW6 | |
| LGGPVRPVLVAPAVS | 61 | Q8NHY2 | |
| PLSPGIKSPTIPRAE | 561 | Q9P2B4 | |
| PLPAARPAGATLERP | 1156 | P04626 | |
| ATLPNPRLGAPAVPR | 121 | P59051 | |
| ISLPPSTPPTRVGVF | 396 | Q6UXE8 | |
| AIARALPAGPRPSTP | 141 | P46092 | |
| APVPTSGAKRPTLPV | 26 | Q8N8Q8 | |
| QLSTLPEPPAARTPG | 106 | Q9Y4M8 | |
| PPGPSRPAVRLVDAV | 936 | O00192 | |
| FSPPRLPVAGLSAPA | 61 | Q16619 | |
| LAAPIIPTPVLTSPG | 191 | Q14203 | |
| PPTPPATSALQQGLR | 361 | Q13202 | |
| PVRFLDPLPTSGITP | 281 | Q5T440 | |
| PSPAGAPRITSVIPS | 136 | O15085 | |
| PLLTDRAPEPPTQVG | 101 | Q6UWD8 | |
| RPTPLVTAGPLVTPT | 86 | Q96SM3 | |
| VPSPGLPVSAPILVR | 141 | Q8N884 | |
| PALPPEGTLARSPSI | 521 | Q9UQB3 | |
| AASPVPPPLVRVAPS | 11 | Q4G0W2 | |
| PPPLVRVAPSLFLGS | 16 | Q4G0W2 | |
| APPVRDLGSVPPELT | 701 | O14641 | |
| TVGVASLLPPPIAPL | 1286 | Q9UKP4 | |
| PAPVEGVLAPSPARL | 481 | O43918 | |
| GVLAPSPARLAPGPA | 486 | O43918 | |
| VLPVGQTAPSRVLPP | 486 | Q6IQ32 | |
| PRPLPAVPGELTEAT | 111 | P54802 | |
| TPIGNSRPSPILEPG | 376 | Q92481 | |
| RVTPLPSLASPAVPA | 176 | Q8NCD3 | |
| GSPLVVPPPTDSARL | 566 | Q5JR59 | |
| ALAPVSGVVLPAPPA | 26 | Q96S59 | |
| AVPNLASVGTRLPPP | 401 | Q9P2N5 | |
| APVRSPQGPSPVLAE | 371 | Q99638 | |
| PLSSRAGAPPAAVPI | 366 | P48382 | |
| PRVPSPIAQATGSPV | 586 | Q6IPM2 | |
| IPGQPPASARRLSVP | 381 | P78412 | |
| ARTVGPPTPAARIPA | 171 | Q9Y4B5 | |
| PPTPAARIPAVTLAV | 176 | Q9Y4B5 | |
| VPPGRLAGPPAVATS | 71 | Q12849 | |
| QVTADLPVPLGAPRP | 456 | Q8N6L0 | |
| IAGPATAPAPRPLGS | 486 | O75427 | |
| TPASATLGRPPRIPE | 176 | Q9P2A4 | |
| EVVRVPLPPPNGASS | 281 | O75106 | |
| VFSGTPPPPVLSFRL | 666 | O14526 | |
| SLPGPTATGPVLLPF | 13311 | Q8WXI7 | |
| IIGSPPVRAVPIGTP | 181 | Q86TB9 | |
| APPGTPIVSPRAVHA | 2081 | Q96JQ0 | |
| PLLSTPAPEARPVIG | 486 | Q96AD5 | |
| TLEPSPTARAAVPLP | 971 | Q96DN6 | |
| ITAAAAKVPTPPGVP | 166 | P55771 | |
| ALPPVSALQPGLTVP | 371 | Q5VYV0 | |
| TAPLQAPTLRGPEPA | 601 | Q9BR39 | |
| VLRPPSPLLPVAAAA | 6 | Q15139 | |
| LSVPLPAEPSPGARA | 636 | Q02779 | |
| VSSLPPFIAPPGRVL | 2951 | Q8NEZ4 | |
| STLGEAPAPPPLSVR | 516 | Q8IVU1 | |
| APAPPPLSVRVLGSS | 521 | Q8IVU1 | |
| PLSRGPVPAKPTVLF | 371 | Q66K74 | |
| GVLPSPATPRFSVPT | 1036 | Q71F56 | |
| GLVPAAPPKRPAVAS | 746 | P27816 | |
| STLRPGPAAPIALVP | 181 | O95944 | |
| PEAAVLRTPLPGVIP | 196 | Q9NVR5 | |
| PPSRPTVGLTPVAEL | 601 | Q99607 | |
| LQPPPAATELGPRTS | 331 | Q86YD7 | |
| RITLPPSLPGPVLVN | 1986 | Q8NDA2 | |
| PSLPGPVLVNTPVRL | 1991 | Q8NDA2 | |
| GVDPPPRARAASVIP | 41 | Q8N5S9 | |
| ILARDGPNALTPPPT | 71 | P05023 | |
| LPRPSISAEPGTVIP | 26 | Q6GTX8 | |
| LTRAPVPPGPAAALL | 26 | P27539 | |
| RVPSPATPLVVAAPA | 6 | Q5U5R9 | |
| VPVTRPALGSTTPPA | 101 | P15941 | |
| SLSLGRPRQAPVPPA | 1776 | Q9P219 | |
| ALVPTQAVPGSPRDP | 366 | P98095 | |
| SPDLAPLRPAAPGQT | 161 | Q12796 | |
| LESQRPPAGIPVAPS | 426 | Q9BX97 | |
| APSVANPVRSPPELG | 1106 | Q9UIW2 | |
| RALSSAGPIPIRPPI | 576 | Q765P7 | |
| PQRLPRSAPPGSLVT | 576 | Q9Y5F6 | |
| APDIAITPLAAPGAP | 351 | O95206 | |
| LIPPARIAVPSPLDA | 1361 | Q9C000 | |
| APRGTPAPQPTITIL | 36 | Q11130 | |
| RSPLEPTPGRFPAVA | 136 | A0A1B0GVZ6 | |
| RGRVFSPVPVPLPTN | 46 | Q86UT5 | |
| PSRTAVPPGLSSLPL | 311 | Q6ZTU2 | |
| LGRVPSPVLPGVSSP | 196 | Q9NQ87 | |
| PSPTLGSPRLPEAQV | 1261 | Q9ULI4 | |
| TPTPLLLVGDRSPVP | 601 | Q8N3F8 | |
| VLRGPPAPAPRVAVT | 886 | Q9BSJ2 | |
| VLRPAVATSPAPGPL | 956 | Q96RT7 | |
| AAPVTPLRPPGLGSA | 416 | Q8IVH2 | |
| PVPPRTGPVAVASLR | 1641 | Q6ZVL6 | |
| PVVTHRSPPLAVPAG | 296 | Q9BTN0 | |
| RSPPLAVPAGRPAAL | 301 | Q9BTN0 | |
| PAPALSPALGPTLSV | 301 | A1L453 | |
| VASFVPRPGPLKPSL | 226 | Q8N7R1 | |
| PSPLGPTRDPVATFL | 666 | Q0VG06 | |
| LVPQSPPTDLPGLTR | 531 | O95402 | |
| PPPTLSPAAITVGRG | 611 | Q8NDX5 | |
| SARASIPPGVPALPV | 306 | Q86Y01 | |
| GPPVGEPRLLASSPA | 156 | Q9NYZ3 | |
| GSLAIPAPSIRLVPP | 11 | A8MVS5 | |
| TPLVPIVVEPARPGA | 1431 | Q9Y2H9 | |
| RSPLEPTPGRFPAVA | 136 | A6NE82 | |
| ISQSALPPLPGSPAI | 251 | Q8IWW6 | |
| LSPRIDGPPTPASLR | 776 | O94913 | |
| IPPAPVVPLLAGAVA | 386 | Q9BZG2 | |
| RPVSVAGSPLSPGPV | 381 | Q9Y4H2 | |
| VGSRQPLPPPRLVAT | 771 | A1KZ92 | |
| FGPSLIRPRPTTAPI | 846 | Q52LW3 | |
| PGIRAPSPVPASSLQ | 81 | Q9NRJ2 | |
| APGATSLPVAIPAPR | 1116 | O95996 | |
| PSPLGPLAGSPVIAA | 361 | Q8NEV1 | |
| PSPVAPLPTRTEGVI | 566 | Q14721 | |
| SAVPLILPQAPSGPS | 506 | A0AVK6 | |
| VGPCLRPSPAPSVAL | 341 | Q8IXT2 | |
| PALPGRPSQLAPATL | 356 | I3L273 | |
| PRPVAVAVAVSPPLE | 106 | P49918 | |
| APVPVPAASLRPLSP | 86 | Q96MA1 | |
| SASLTRGPQPPPLAV | 401 | Q6UUV9 | |
| CAAPISVPGVTRPSP | 266 | Q6ZN03 | |
| ETTSLLPAIAAPPPG | 691 | Q5JV73 | |
| PPLPGAAPSVVLTVG | 541 | Q8IVF7 | |
| LNPDLPSGRTPTVAP | 26 | Q96AQ9 | |
| VTAEGLSVAPAPPPL | 6 | F5H4A9 | |
| PSPLGPLAGSPVIAA | 361 | P68400 | |
| LSPVAPLSPARLQGP | 356 | P41970 | |
| TLPAPPAQAPLRGTV | 1066 | Q6VMQ6 | |
| AAPLPAGRPRPTTNL | 601 | Q96L34 | |
| TAPGEVPALSNLRPP | 146 | P28300 | |
| AGNIPLSPLARTPSP | 1371 | O15021 | |
| PSGDVRASVPPVLPS | 1831 | O15021 | |
| ILARDGPNALTPPPT | 61 | P13637 | |
| LGPPAVAPSRIRTLP | 911 | Q8TEH3 | |
| PAISRLQAAPAGPSP | 181 | Q12952 | |
| TASLVGVGLPPPTPR | 156 | Q63ZY3 | |
| PSIVPPAVSLAPGVL | 381 | Q7Z7F0 | |
| PAVSLAPGVLPALPT | 386 | Q7Z7F0 | |
| GATVTRGVPPPPTVR | 326 | Q07666 | |
| PPVVSPNGTRLSPIA | 331 | Q13118 | |
| SVSPAVPGRSPGLPI | 341 | Q14CZ8 | |
| APALRAPPSGSLGPV | 226 | Q9Y5J3 | |
| APPSGSLGPVLPVVT | 231 | Q9Y5J3 | |
| PVPPVPERRGSLTLT | 926 | Q6ZRV2 | |
| AVAPGLGSSPLVPAP | 326 | Q9NZM4 | |
| ITSQPLGPRIIAPPS | 1766 | D6RIA3 | |
| RLMLPPPPLTASGVF | 391 | P18858 | |
| AGIPPPVVTPVLAST | 136 | Q9UPN6 | |
| PLTPETRAITLFPPG | 1736 | P21817 | |
| EGPVARPLSPTRLQP | 481 | Q8WUF5 | |
| PAAGAAPSPRPLSLV | 6 | Q6NUT3 | |
| PGAPLEATRRPAPAL | 21 | Q5T6X4 | |
| VPLLLPPASAETVGP | 91 | O75474 | |
| VGLPPPARTSPLVSG | 241 | Q2NL67 | |
| VRSPPAAPAVAPLTP | 591 | Q96RD6 | |
| PPTVSRCAPGKPTLV | 726 | Q9UN75 | |
| RSPLEPTPGRFPAVA | 136 | Q8NHZ7 | |
| VASAAPAPGPPRQLV | 881 | Q96AX9 | |
| GDLPAPVTPQPRSIS | 41 | Q8NFH5 | |
| AAASGAAIPPLIPPR | 131 | O14654 | |
| LLLPAVPVGASVPPR | 21 | O75095 | |
| LPQSPVPASGLLSPE | 776 | Q8IVF1 | |
| LPQSPVPASGLLSPE | 776 | A6NNL0 | |
| LPQSPVPASGLLSPE | 776 | B1AL46 | |
| AVVPPAGPLVLSAFP | 46 | A1L443 | |
| AVVPPAGPLVLSAFP | 46 | Q5VZR2 | |
| SSPILLPTPVVGGPR | 241 | Q9BST9 | |
| TLPGSAEPPLTAVRP | 386 | Q9BZR6 | |
| GPRPRDFVTISPVQP | 141 | Q9H611 | |
| SIGFVLVPLRPPSPA | 2926 | Q5T011 | |
| PAITFTTPLGPIRSP | 596 | Q8IW52 | |
| VRTLQAPPEGLSPPV | 4256 | O75445 | |
| RGLPVGSPPESIISP | 3291 | P46939 | |
| LPQSPAIPVSGPVRL | 116 | Q8NA92 | |
| APGVITGVTPARPPI | 376 | Q9UHX1 | |
| ISEGPVPSLPIRPSR | 1056 | O43426 | |
| PTIPPRAGVISAPQS | 1196 | O43426 | |
| SLPPIVTPASRRLGP | 21 | P0C7N4 | |
| SLPPIVTPASRRLGP | 21 | A6NGB0 | |
| VTPSSRPAPGPALAL | 111 | H3BV60 | |
| AEGTTGPRLPLPSVP | 786 | Q6ZMQ8 | |
| GGPPPVRALTPLTSS | 216 | O95486 | |
| VPRLAGPPQSLPSRI | 526 | Q15572 | |
| GPPQSLPSRIDSLPA | 531 | Q15572 | |
| IGLAAVVPPLPSAPT | 566 | Q15572 | |
| DPLATPPIATRAPSI | 341 | Q9HDB5 | |
| LPLPPVPRGAQAAVS | 21 | Q9NTG1 | |
| PPARITGVGAVPLPA | 356 | Q9UL41 | |
| PPPVTPAALRVLGAA | 36 | Q9H6K5 | |
| SPTRGPRGVALAPTP | 71 | Q9UPR0 | |
| VVRRSSPQPGPLPGT | 261 | Q6UWY2 | |
| PPVTGPRSALAPNLL | 156 | O15446 | |
| TPALQPLSRASPIPG | 1071 | Q9P2F8 | |
| PLSRASPIPGTPDRL | 1076 | Q9P2F8 | |
| SPRPLLVPDEGPTAL | 1711 | Q5T5P2 | |
| TRAAPLTPIGTPLPS | 1346 | Q8TF72 | |
| TALSPSLPVPGLRPQ | 136 | Q8N8Z3 | |
| SGPLIPPASPRLGNT | 141 | A6NGB9 | |
| RLPPPFVPTLSGRTD | 886 | Q16512 | |
| PGAVPSGPPLSRVAT | 326 | Q8N4L1 | |
| AIQPLPLSPGVRPAS | 871 | Q9NQW1 | |
| PLSPGVRPASSQPQL | 876 | Q9NQW1 | |
| PTLATPPAGQTLAVP | 76 | Q6UXD5 | |
| PPAGQTLAVPSLPRA | 81 | Q6UXD5 | |
| VSASPAGPPLIPASR | 1051 | Q6ZRS2 | |
| TTAVPAPTPAPQRLI | 1156 | Q6ZRS2 | |
| SGLPAVLNPRPTLTP | 1336 | Q6ZRS2 | |
| GPTQTLSLAPAPPLA | 1741 | Q6ZRS2 | |
| CTLPQPVASPIGPRS | 1926 | Q6ZRS2 | |
| TPASAPAAIPALVPV | 2446 | Q6ZRS2 | |
| PLLLGPPSVPISASV | 2526 | Q6ZRS2 | |
| PSAPVVLGPAARTTP | 146 | Q9P1W8 | |
| LEPALPPGSRVILPT | 131 | Q8NFA2 | |
| PVPGAPKAPAATSIL | 386 | Q969V6 | |
| SAPPARLVEVPAAPV | 126 | Q9H6W3 | |
| VAPQAPSSILLPAAP | 736 | Q8WZ75 | |
| AAGPALSPVPPVVHL | 81 | P10415 | |
| APSLPRPLPATVGVT | 821 | Q8IUL8 | |
| ILRPAPLPAAVVPST | 656 | Q6ZRI6 | |
| GLAAPSLTPPQLATP | 131 | Q9ULV3 | |
| LREIAPGPLTTPSVP | 196 | Q96EP0 | |
| AGPRSPPVTLGPNLA | 146 | Q15735 | |
| PPVTLGPNLAPTSRD | 151 | Q15735 | |
| APASRPLPTVVLAPQ | 206 | Q5VWI1 | |
| VLPPASPSNGPALLR | 311 | Q9UM82 | |
| LEPSIPPPRIASGAR | 1846 | Q86UP3 | |
| QAPRRSAPLGPVAPT | 41 | Q9NUR3 | |
| FQVRPGLPPTPVART | 501 | Q5GH72 | |
| RLPPGSTELTLPTPA | 1221 | O14924 | |
| RASTPQPAPAGVPAL | 3136 | Q96T58 | |
| SPLVAPPAALPSDGR | 266 | O15027 | |
| PRSASAPGAPPLVRV | 111 | Q2M3V2 | |
| LPRGLPPTSLQVPAA | 1076 | Q9UPX0 | |
| LRLPPGAPGPVTSTT | 441 | C9JR72 | |
| VPATPPRTGSPLTIG | 256 | Q9BQI5 | |
| PARPIPGQSAAPTLA | 136 | Q8TEJ3 | |
| IAPRLLASAAPGPPE | 46 | Q8WZ71 | |
| GRPLTSSPDPVPVRV | 191 | Q6ZMY3 | |
| ASPRLSPSPLPVALG | 201 | O14813 | |
| ITARELPPPTSAQGP | 621 | Q9P2H5 | |
| GAFARVSDSIPPLPP | 436 | Q6VEQ5 | |
| APAPVVLGSPVVLGP | 156 | Q6ZN55 | |
| GAFVRVSDSIPPLPP | 436 | A8K0Z3 | |
| APGPPAGVRTTRLPS | 306 | Q96DN2 | |
| SPPRVLELPGVPAAA | 121 | Q9P1Z0 | |
| LLASLRPAEPAVPGP | 241 | P52849 | |
| TSRALPPEPAPALLG | 791 | Q9H3T2 | |
| APVAAGLGPVISRPP | 11 | O43159 | |
| GLGPVISRPPPAASS | 16 | O43159 | |
| PGVDVTLLPAPPARL | 1456 | O95359 | |
| GSAPVAIPGSLPRAP | 456 | Q9H9P5 | |
| PRPALLPTPVSFGSA | 666 | P49750 | |
| PDLIVLQPRGPSVPS | 606 | Q8IUG5 | |
| AVSAPGILNRPPAPT | 226 | O43670 | |
| GILNRPPAPTATVPA | 231 | O43670 | |
| ARLTAPAPTPPLLVA | 206 | Q13470 | |
| PVPLPDTVLLPGASV | 1016 | Q9Y2L5 | |
| PRAPGPLQTLPVAAV | 46 | Q658N2 | |
| GGLPIPPVSESPVLS | 1396 | Q9H4A3 | |
| ILPQAAGPTSTPLLP | 1581 | Q9H4A3 | |
| PATIPLLAVAPPGVA | 881 | Q9Y3S1 | |
| TRPAVPGLPTVVPTL | 56 | Q6NUS6 | |
| RGTLAVNIPPPPTDR | 1031 | Q8IWB9 | |
| IPAPRGTGIVSAPVP | 196 | P15880 | |
| PSQPSDPGVLELPRV | 401 | Q96LC7 | |
| RLVPHPTRAGLPAPT | 171 | Q8WUA8 | |
| PPTPAPILRADLAGI | 161 | Q6DKI7 | |
| PAPLRLGEAAPGTPT | 56 | Q9BT76 | |
| TEADLALRPPPPLGT | 16 | Q96J92 | |
| PTQRLSPGEALPPVS | 936 | Q63HR2 | |
| GPLVSPPIRPSLSEG | 221 | Q8NFA0 | |
| DGLAPPRSPLFSPVV | 51 | Q6SJ96 | |
| TSPLPRAAPDSGLPL | 466 | Q8NBT3 | |
| PSPPALELARGSVAP | 66 | Q8NBI6 | |
| SLVPPEARSPGSLLP | 256 | Q9H0D2 | |
| PQVLATSPAVLPAPA | 131 | Q9NW07 | |
| LLPPVVGGSIPVSSP | 301 | Q9UGR2 | |
| PAPSDRSGPQILTPL | 581 | Q9P206 | |
| PALAAPAVVPGPVST | 626 | Q9P206 |